Celgene Corp
CELG
CELG was delisted on the 20th of November, 2019.
1,031 hedge funds and large institutions have $62.2B invested in Celgene Corp in 2014 Q3 according to their latest regulatory filings, with 100 funds opening new positions, 391 increasing their positions, 410 reducing their positions, and 56 closing their positions.
79% more first-time investments, than exits
New positions opened: 100 | Existing positions closed: 56
32% more funds holding in top 10
Funds holding in top 10: 76 → 100 (+24)
11% more capital invested
Capital invested by funds: $56.1B → $62.2B (+$6.11B)
4% more funds holding
Funds holding: 995 → 1,031 (+36)
5% less repeat investments, than reductions
Existing positions increased: 391 | Existing positions reduced: 410
31% less call options, than puts
Call options by funds: $970M | Put options by funds: $1.4B
Top Buyers
Top Sellers
| 1 |
Norges Bank
Oslo,
Norway
|
-$512M |
| 2 |
JP Morgan Chase
New York
|
-$233M |
| 3 |
MCM
Marsico Capital Management
Denver,
Colorado
|
-$213M |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$146M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$132M |
CELG Hedge Fund Activity: Q3 2014 in Review
1,031 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q3 2014, worth a combined $62.2B — up 11% from $56.1B a quarter earlier.
Buyers outnumbered sellers: 100 funds opened new CELG positions and 56 closed out — a net gain of 44 holders — while 391 added to existing stakes and 410 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $626M. The largest seller was Norges Bank, cutting an estimated $512M.
- 1,031 institutional investors held Celgene Corp (CELG) as of Q3 2014, up from 995 in Q2 2014.
- Funds reported $62.2B of Celgene Corp stock for Q3 2014, up 11% quarter-over-quarter.
- 100 funds opened new Celgene Corp positions in Q3 2014 and 56 closed out, a net change of +44 holders.
- The largest Celgene Corp buyer in Q3 2014 was Fidelity Investments, an estimated $626M added.
- The largest Celgene Corp seller in Q3 2014 was Norges Bank, an estimated $512M sold.
Based on aggregated 13F filings for Q3 2014.